Invited talk – John Murphy

"Novel therapeutic targets in human blood cell malignancies: SLAMF7 receptor as a promising therapeutic target in multiple myeloma and B CLL”. Innovative Technologies in Clinical Immunology: From Immunodiagnostics and Immunotherapy to Personalized Targeted Immunorehabilitation, Tbilisi, Georgia, 19 June 2018